Merlin Capital’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-104,958
Closed -$968K 54
2022
Q4
$968K Buy
104,958
+51,642
+97% +$616K 2.38% 9
2022
Q3
$650K Buy
53,316
+721
+1% +$10.6K 1.51% 20
2022
Q2
$694K Buy
52,595
+10,622
+25% +$266K 1.39% 18
2022
Q1
$1.68M Buy
41,973
+2,978
+8% +$126K 2.22% 15
2021
Q4
$2.11M Buy
+38,995
New +$2.62M 2.44% 12

Other funds holding ACB

Merlin Capital's ACB Position: Q1 2023 in Review

Merlin Capital sold out of Aurora Cannabis (ACB) in Q1 2023, closing a stake of 104,958 shares — an estimated $968K sold.

Merlin Capital first reported a position in ACB in Q4 2021 and held it in 5 quarters. The position peaked at $2.11M in Q4 2021. 216 funds tracked by Wall St. Rank hold ACB as of Q1 2023.

  • Merlin Capital reported no remaining Aurora Cannabis position as of Q1 2023 after selling out during the quarter.
  • Merlin Capital sold 104,958 Aurora Cannabis shares in Q1 2023, an estimated $968K.
  • Merlin Capital first reported a position in Aurora Cannabis in Q4 2021 and held it in 5 quarters.
  • Merlin Capital's Aurora Cannabis position peaked at $2.11M in Q4 2021.
  • 216 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2023.

Based on Merlin Capital's 13F filing for Q1 2023, filed 16 May 2023.